MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cullinan Therapeutics (CGEM) Earnings Date & Reports
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer... Show more
A.I. Advisor
published Earnings
CGEM is expected to report earnings to rise 4.36% to -84 cents per share on November 05
Q3'26
Est.
$-0.85
Q2'26
Est.
$-0.81
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.01
Q3'25
Beat
by $0.18
The last earnings report on August 06 showed earnings per share of -81 cents, meeting the estimate of -81 cents. With 557.67K shares outstanding, the current market capitalization sits at 1.32B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
109
Web
https://www.cullinantherapeutics.com